Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$5.67

0.1 (1.80%)

06:11
08/11/17
08/11
06:11
08/11/17
06:11

TherapeuticsMD announcement a 'small positive,' says Deutsche Bank

Deutsche Bank analyst Esther Rajavelu views TherapeuticsMD's announcement that the FDA will review in detail, as part of the data package for TX-004, a large NIH-sponsored observational study on long-term, real world use of vaginal estrogens as a "small positive." While the analyst remains cautious on the timing and outcome of the review, she sees the news as an "incremental step in the right direction." Rajavelu continues to model for a TX-004 launch in 2019. The analyst keeps a Buy rating on TherapeuticsMD with a $10 price target.

TXMD TherapeuticsMD
$5.67

0.1 (1.80%)

07/11/17
OPCO
07/11/17
UPGRADE
Target $10
OPCO
Outperform
TherapeuticsMD upgraded ahead of FDA meeting update at Oppenheimer
Oppenheimer analyst Jay Olson upgraded TherapeuticsMD to Outperform from Perform with a $10 price target. The stock closed yesterday down 21c to $4.80. Details of the company's meeting with the FDA are likely to be announced around July 14 and there is a "reasonable probability" of positive news, Olson tells investors in a research note. Evidence supports a scenario where TherapeuticsMD is likely to resubmit TX-004HR by July 31 with a potential FDA approval by September 29 in the best case, the analyst adds. He assigns a 60% probability to this scenario.
07/17/17
STFL
07/17/17
NO CHANGE
Target $20
STFL
Buy
Stifel sees high likelihood FDA lets TherapeuticsMD do post-marketing study
Stifel analyst Annabel Samimy said a lack of clarity is pressuring TherapeuticsMD shares after the company provided a regulatory update on the status of its New Drug Application for TX-004HR, but he thinks there is a high likelihood that the FDA will allow the company to proceed with a post-marketing safety study. Samimy, who still expects a resubmission within weeks and FDA action within two months, keeps a Buy rating and $20 price target on TherapeuticsMD.
07/21/17
DBAB
07/21/17
INITIATION
Target $10
DBAB
Buy
TherapeuticsMD initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Esther Rajavelu started TherapeuticsMD with a Buy rating and $10 price target. Current trading levels do not fully reflect the TX-001 market opportunity and provide an attractive entry point for investors, the analyst contends. Rajavelu sees upside from current trading levels regardless of the regulatory outcome for TX-004.
08/04/17
OPCO
08/04/17
NO CHANGE
Target $10
OPCO
Outperform
TherapeuticsMD talks with FDA increasingly collaborative, says Oppenheimer
After TherapeuticsMD provided an update on the regulatory process for both TX-004HR and TX-001HR, Oppenheimer analyst Jay Olson says he believes the narrative between the company and the FDA has become "more collaborative." This suggests next week's potential update on TX-004HR could be favorable, Olson tells investors in a research note. The analyst keeps an Outperform rating on TherapeuticsMD with a $10 price target.

TODAY'S FREE FLY STORIES

PLNT

Planet Fitness

$30.15

0.07 (0.23%)

17:58
11/20/17
11/20
17:58
11/20/17
17:58
Initiation
Planet Fitness initiated  »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$44.43

0.86 (1.97%)

17:57
11/20/17
11/20
17:57
11/20/17
17:57
Downgrade
Teradyne rating change  »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

CBS

CBS

$55.93

-0.81 (-1.43%)

17:56
11/20/17
11/20
17:56
11/20/17
17:56
Periodicals
CBS News suspends Charlie Rose following sexual harassment claims, AP says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$55.93

-0.81 (-1.43%)

17:55
11/20/17
11/20
17:55
11/20/17
17:55
Periodicals
Eight women accuse Charlie Rose of sexual harassment, Washington Post says »

Eight women have said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$51.05

1 (2.00%)

, MRVL

Marvell

$21.59

1.3 (6.41%)

17:53
11/20/17
11/20
17:53
11/20/17
17:53
Hot Stocks
Starboard Value reports 9.8% stake in Mellanox, may seek talks »

Peter A. Feld, a…

MLNX

Mellanox

$51.05

1 (2.00%)

MRVL

Marvell

$21.59

1.3 (6.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

CDXS

Codexis

17:46
11/20/17
11/20
17:46
11/20/17
17:46
Hot Stocks
Breaking Hot Stocks news story on Codexis »

Telemark Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:45
11/20/17
11/20
17:45
11/20/17
17:45
Hot Stocks
AT&T CEO says giving up control of CNN is a 'non-starter' »

Says plenty of solutions…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BBY

Best Buy

$56.35

0.52 (0.93%)

17:45
11/20/17
11/20
17:45
11/20/17
17:45
Conference/Events
Best Buy management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:43
11/20/17
11/20
17:43
11/20/17
17:43
Hot Stocks
AT&T CEO says DOJ suit 'defies logic' »

Says has offered…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RELY

Real Industry

$0.52

0.1643 (45.92%)

17:38
11/20/17
11/20
17:38
11/20/17
17:38
Hot Stocks
Real Industry, Real Alloy receive court approval of 'first day' motions »

Real Industry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAVN

Raven

$34.65

0.85 (2.51%)

17:34
11/20/17
11/20
17:34
11/20/17
17:34
Earnings
Raven reports Q3 EPS 33c, consensus 23c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ONTX

Onconova

$1.70

0.01 (0.59%)

17:34
11/20/17
11/20
17:34
11/20/17
17:34
Syndicate
Breaking Syndicate news story on Onconova »

Onconova files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ONTX

Onconova

$1.70

0.01 (0.59%)

17:33
11/20/17
11/20
17:33
11/20/17
17:33
Syndicate
Breaking Syndicate news story on Onconova »

Onconova files $84.55M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MLNX

Mellanox

$51.05

1 (2.00%)

17:31
11/20/17
11/20
17:31
11/20/17
17:31
Hot Stocks
Starboard Value reports 9.8% stake in Mellanox »

Starboard has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

  • 06

    Dec

ASYS

Amtech Systems

$14.12

0.93 (7.05%)

, PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

17:27
11/20/17
11/20
17:27
11/20/17
17:27
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Amtech…

ASYS

Amtech Systems

$14.12

0.93 (7.05%)

PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

URBN

Urban Outfitters

$28.27

0.37 (1.33%)

CLSN

Celsion

$2.14

0.14 (7.00%)

SNSS

Sunesis

$2.87

0.01 (0.35%)

HAIN

Hain Celestial

$40.89

1.05 (2.64%)

NSRGY

Nestle

$85.14

0.03 (0.04%)

A

Agilent

$69.96

1.17 (1.70%)

BECN

Beacon Roofing

$56.28

0.65 (1.17%)

INTU

Intuit

$157.78

1.23 (0.79%)

SNCR

Synchronoss

$11.14

0.76 (7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 30

    Nov

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

SNGX

Soligenix

$2.24

0.02 (0.90%)

17:23
11/20/17
11/20
17:23
11/20/17
17:23
Syndicate
Breaking Syndicate news story on Soligenix »

Soligenix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIB

CTI Industries

$3.56

-0.269 (-7.03%)

17:23
11/20/17
11/20
17:23
11/20/17
17:23
Hot Stocks
CTI Industries names Frank Cesario CFO »

CTI Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$38.90

1.35 (3.60%)

17:22
11/20/17
11/20
17:22
11/20/17
17:22
Hot Stocks
SolarEdge chairman, CEO Sella diagnosed with colon cancer »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

17:20
11/20/17
11/20
17:20
11/20/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Stanley Furniture »

Stanley Furniture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLAD

Gladstone Capital

$9.76

-0.02 (-0.20%)

17:09
11/20/17
11/20
17:09
11/20/17
17:09
Earnings
Gladstone Capital reports Q4 NII 21c, consensus 21c »

Reports NAV per share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:07
11/20/17
11/20
17:07
11/20/17
17:07
Hot Stocks
Breaking Hot Stocks news story on AT&T, Time Warner »

Department of Justice…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

LMT

Lockheed Martin

$314.65

4.95 (1.60%)

17:07
11/20/17
11/20
17:07
11/20/17
17:07
Hot Stocks
Lockheed Martin awarded $122.3M U.S. Navy contract »

ockheed Martin Rotary and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

ZTO

ZTO Express

$17.00

0.17 (1.01%)

17:02
11/20/17
11/20
17:02
11/20/17
17:02
Earnings
Breaking Earnings news story on ZTO Express »

ZTO Express sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MSG

Madison Square Garden

$215.00

-3.46 (-1.58%)

17:01
11/20/17
11/20
17:01
11/20/17
17:01
Hot Stocks
Madison Square Garden acquires Obscura Digital, terms not disclosed »

The Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTO

ZTO Express

$17.00

0.17 (1.01%)

17:01
11/20/17
11/20
17:01
11/20/17
17:01
Earnings
ZTO Express reports Q3 EPS 15c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.